Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
I-MAB (IMAB)
NASDAQ:IMAB
I-MAB (IMAB) Stock Price & Analysis
221 Followers
IMAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $3.45
Previous Close$1.82
Volume96.27K
Average Volume (3M)294.75K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.34B
Total Debt (Recent Filing)¥10.87M
Price to Earnings (P/E)-0.7
Beta1.21
Next Earnings
Aug 27, 2024EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.58
Shares Outstanding80,701,592
10 Day Avg. Volume144,684
30 Day Avg. Volume294,749
Standard Deviation0.21
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.05
Price to Sales (P/S)-0.66
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.25Price Target Upside305.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
I-MAB News
PremiumCompany Announcements
Patent Law Changes Pose Threat to I-Mab Adr’s Drug Candidate Protection
PremiumCompany Announcements
I-Mab Announces CMO Transition, Interim Successor Named
PremiumCompany Announcements
I-Mab Finalizes Divestiture and Resolves Obligations
PremiumCompany Announcements
I-Mab Announces Major Leadership Reshuffle
Ownership Overview
0.00%
Insiders
2.25% Mutual Funds
0.51% Other Institutional Investors
97.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMAB FAQ
What was I-MAB’s price range in the past 12 months?
I-MAB lowest stock price was $1.16 and its highest was $3.45 in the past 12 months.
What is I-MAB’s market cap?
Currently, no data Available
When is I-MAB’s upcoming earnings report date?
I-MAB’s upcoming earnings report date is Aug 27, 2024 which is in 109 days.
How were I-MAB’s earnings last quarter?
I-MAB released its earnings results on Mar 14, 2024. The company reported -$0.481 earnings per share for the quarter, beating the consensus estimate of -$0.84 by $0.359.
Is I-MAB overvalued?
According to Wall Street analysts I-MAB’s price is currently Undervalued.
Does I-MAB pay dividends?
I-MAB does not currently pay dividends.
What is I-MAB’s EPS estimate?
I-MAB’s EPS estimate is -$0.35.
How many shares outstanding does I-MAB have?
I-MAB has 80,701,590 shares outstanding.
What happened to I-MAB’s price movement after its last earnings report?
I-MAB reported an EPS of -$0.481 in its last earnings report, beating expectations of -$0.84. Following the earnings report the stock price went up 3.333%.
Which hedge fund is a major shareholder of I-MAB?
Among the largest hedge funds holding I-MAB’s share is Caxton Associates LP. It holds I-MAB’s shares valued at N/A.
---
I-MAB Stock Smart Score
Company Description
I-MAB
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
---
IMAB Stock 12 Month Forecast
Average Price Target
$7.25
▲(305.03% Upside)
Technical Analysis
Molecular Templates
―
Rhythm Pharmaceuticals
―
ImmunoCellular Therapeutics
―
Immatics
―
Best Analysts Covering IMAB
1 Year
---